CN117903074A - Preparation method of 4, 5-dihydro-isoxazole-3-carboxylic acid compound - Google Patents

Preparation method of 4, 5-dihydro-isoxazole-3-carboxylic acid compound Download PDF

Info

Publication number
CN117903074A
CN117903074A CN202410054241.8A CN202410054241A CN117903074A CN 117903074 A CN117903074 A CN 117903074A CN 202410054241 A CN202410054241 A CN 202410054241A CN 117903074 A CN117903074 A CN 117903074A
Authority
CN
China
Prior art keywords
acid
optionally substituted
compound
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202410054241.8A
Other languages
Chinese (zh)
Inventor
邓照西
郭少雄
胡合伟
岑金
杨莉娜
李君沛
王俊珂
李志军
杜兵兵
李绍文
田超阁
何云梦
高嘉薇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhengzhou Institute Of Chiral Drugs Research Co ltd
Original Assignee
Zhengzhou Institute Of Chiral Drugs Research Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhengzhou Institute Of Chiral Drugs Research Co ltd filed Critical Zhengzhou Institute Of Chiral Drugs Research Co ltd
Priority to CN202410054241.8A priority Critical patent/CN117903074A/en
Publication of CN117903074A publication Critical patent/CN117903074A/en
Pending legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention discloses a preparation method of a 4, 5-dihydro-isoxazole-3-carboxylic acid compound, which comprises the following synthetic route: Wherein R 1、R2, X and n are defined as in the specification.

Description

Preparation method of 4, 5-dihydro-isoxazole-3-carboxylic acid compound
Technical Field
The invention belongs to the field of organic synthesis, and particularly relates to a preparation method of a4, 5-dihydro-isoxazole-3-carboxylic acid compound.
Background
The 4, 5-dihydro-isoxazole compounds are compounds with good biological activity and potential medicinal value, wherein 4, 5-dihydro-isoxazole-3-carboxylic acid compounds such as 5-phenyl-4, 5-dihydro-isoxazole-3-carboxylic acid ethyl ester (ethyl monobenzoate) and 5, 5-diphenyl-4, 5-dihydro-isoxazole-3-carboxylic acid ethyl ester (ethyl bisbenzoate) can be used as herbicide safeners. The existing method for synthesizing ethyl bisbenzoxazolate and ethyl monobenzoxazolate has the problems of longer route or lower yield or using more expensive raw materials, such as the synthetic route of ethyl bisbenzoxazolate provided by patent CN108440435A (shown below), and the yield of the cyclization step of the ethyl bisbenzoxazolate and the ethyl chloroximinoacetate is only about 34 percent (example 1)
Literature (KatrinThommes,OlefinCyclopropanationsviaSequentialAtomTransferRadical Addition-DechlorinationReactions,Chimia.2010;64(3):188-190) reports a synthetic method of ethyl monobenzoate intermediate (shown below), which is to obtain 1-phenyl-2-carboxylic acid ethyl ester cyclopropane through two steps of reactions, wherein the first step is Ru-catalyzed atom transfer radical addition, and the second step is dechlorination.
The route uses a relatively expensive ruthenium catalyst, and increases the preparation cost of the compound.
Disclosure of Invention
Aiming at the defects of low yield, high price of metal catalyst and the like existing in the prior art for preparing 4, 5-dihydro-isoxazole-3-carboxylic acid compounds, the invention provides a method with simple preparation method, high yield and low production cost.
Specifically, the invention provides a preparation method of a compound of formula I, which comprises the following steps:
Step one, reacting a compound of formula III with dichloroacetic acid or ester thereof and magnesium metal in the presence of DMF and/or DMAC to prepare a compound of formula II;
step two, preparing a compound of the formula I from the compound of the formula II in the presence of acid and sodium nitrite,
The synthetic route is as follows:
wherein,
X is selected from optionally substituted alkyl, optionally substituted alkoxy, cyano, ester, nitro, amide, halogen, haloalkyl;
R 1 is selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted alkoxy-alkyl, optionally substituted cycloalkyl, optionally substituted heterocyclyl, and optionally substituted aryl;
R 2 is selected from hydrogen, optionally substituted alkyl;
n is selected from natural numbers from 0 to 5, particularly preferably 0, 1,2 and 3.
The beneficial effects of the invention are that
1. In the synthetic route of the invention, the stilbene reacts with ethyl dichloroacetate to generate the three-membered ring derivative, and then reacts with sodium nitrite to generate the isoxazole ring, the yield of the two steps can reach 96%, and the yield is greatly improved.
2. The invention adopts a completely different reaction route from the prior art, and carries out the reaction by different reaction mechanisms, does not need expensive catalyst, has easily obtained raw materials and mild reaction conditions, and is more suitable for industrial production.
Detailed Description
For the purpose of making the objects, technical solutions and advantages of the embodiments of the present invention more apparent, the technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is apparent that the described embodiments are some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention. In addition, numerous specific details are set forth in the following description in order to provide a better illustration of the invention. It will be understood by those skilled in the art that the present invention may be practiced without some of these specific details. In some embodiments, raw materials, auxiliary materials, methods, means, etc. well known to those skilled in the art are not described in detail in order to highlight the gist of the present invention.
Throughout the specification and claims, unless explicitly stated otherwise, the term "comprise" or variations thereof such as "comprises" or "comprising" and the like will be understood to include the stated active ingredient without excluding other active ingredients that may be present.
The endpoints and any values of the ranges disclosed herein are not limited to the precise range or value, and are understood to encompass values approaching those ranges or values. For numerical ranges, one or more new numerical ranges may be found between the endpoints of each range, between the endpoint of each range and the individual point value, and between the individual point value, in combination with each other, and are to be considered as specifically disclosed herein.
The term "halogen" in the present invention refers to fluorine, chlorine, bromine and iodine.
The term "alkyl" (and in the case of other groups comprising alkyl groups, such as alkyl moieties of alkoxy groups, alkyl moieties of arylalkyl groups) in the present invention denotes in each case straight-chain or branched alkyl groups having generally from 1 to 20 carbon atoms, often from 1 to 6 carbon atoms, preferably from 1 to 4 carbon atoms, in particular from 1 to 3 carbon atoms. Examples of C 1-C4 alkyl are methyl, ethyl, n-propyl, isopropyl, n-butyl, 1-methylpropyl (sec-butyl), 2-methylpropyl (isobutyl), 1-dimethylethyl (tert-butyl). Examples of C 1-C6 alkyl are, in addition to the radicals mentioned for C1-C4 alkyl, also n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2-dimethylpropyl, 1-ethylpropyl, 1-dimethylpropyl, 1, 2-dimethylpropyl, hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-dimethylbutyl, 1, 2-dimethylbutyl, 1, 3-dimethylbutyl, 2-dimethylbutyl, 2, 3-dimethylbutyl, 3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1, 2-trimethylpropyl, 1, 2-trimethylpropyl, 1-ethyl-1-methylpropyl or 1-ethyl-2-methylpropyl. Examples of the C 1-C10 alkyl group include, but are not limited to, n-heptyl, 1-methylhexyl, 2-methylhexyl, 3-methylhexyl, 1-ethylhexyl, 2-ethylhexyl, 1, 2-dimethylhexyl, 1-propylpentyl, 2-propylpentyl, nonyl, decyl, 2-propylheptyl and 3-propylheptyl groups in addition to the groups mentioned for the C 1-C6 alkyl group. The term "alkoxy" according to the invention refers to an-OR group, wherein R is an alkyl group as defined above, a straight-chain OR branched alkyl group, often of 1 to 6 carbon atoms, preferably of 1 to 4 carbon atoms, especially of 1 to 3 carbon atoms. For example, but not limited to, methoxy, ethoxy, propoxy, or 2-propoxy, n-butoxy, isobutoxy, or t-butoxy.
The term "amide group" in the present invention means a group containing "-NHCO-" or "-CONHCO-" in the group, for example, but not limited to ,-NHCOCH3、-NHCOH、-NHCOCH2CH3、-NHCOCH2CH2CH3、-NHCOCH(CH3)2、-N(COCH3)2、-CONH2、-CON(CH3)2、-CONHCH3、-CONHCH2CH3、-CON(CH2CH3)2、-CONHCH(CH3)2、-CONHCH2CH2CH3、-CONHCH2CH2CH2CH3、 phthalimide group, succinimide group, glutarimide group, maleimide group, etc.
The term "ester group" in the present invention means that the group contains "-COO-" such as, but not limited to ,-COOCH3、-COOCH2CH3、-COOCH(CH3)2、-COOCH2CH2CH3、-COOCH2CH2CH2CH3,.
The term "haloalkyl" according to the invention denotes partially or fully halogenated alkyl groups, which have the meaning given above for alkyl groups, wherein the halogen atom is in particular fluorine, chlorine and/or bromine, i.e. for example chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-difluoroethyl, 2-chloro-2-fluoroethyl, 2, 2-trifluoroethyl group, 2-chloro-1, 2-trifluoroethyl group, 2-chloro-2, 2-difluoroethyl group, 2-bromo-2, 2-difluoroethyl group, 2, 2-dichloro-2-fluoroethyl group, 2-trichloroethyl group, 1, 2-tetrafluoroethyl group, 1, 2-tetrachloroethyl group, pentafluoroethyl group, 2, 2-dichloro-2-fluoroethyl group, 2-trichloroethyl group, 1, 2-tetrafluoroethyl, 1, 2-tetrachloroethyl, pentafluoroethyl.
The term "cycloalkyl" according to the invention refers to a monocyclic monovalent hydrocarbon group of three to eight carbon atoms, which may be saturated or contain one double bond. Cycloalkyl groups may be unsubstituted or substituted with one or two substituents independently selected from alkyl, halogen, alkoxy, hydroxy, or cyano, but are not limited thereto. Examples include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, 1-cyanocyclopropyl-1-yl, 1-cyanomethylcyclopropan-1-yl, 3-fluorocyclohexyl and the like. When cycloalkyl contains a double bond, it may be referred to herein as cycloalkenyl.
The term "heterocycle" according to the present invention refers to a saturated or partially unsaturated carbocyclic ring containing 1 to 4 heteroatoms selected from nitrogen, oxygen and sulfur as ring members. Such rings do not contain adjacent oxygen atoms, adjacent sulfur atoms, or adjacent oxygen and sulfur atoms within the ring. Preferred examples are aziridine, azetidine, pyrrolidine, piperidine, morpholine, piperazine, homopiperazine, tetrahydrofuran, dioxane, 2, 5-diazabicyclo [2, 1] heptane and 3, 7-diazabicyclo [3, 0] octane, and further preferred are aziridine, azetidine, pyrrolidine, piperidine, morpholine, piperazine, homopiperazine, 2, 5-diazabicyclo [2, 1] heptane and 3, 7-diazabicyclo [3, 0] octane.
"Aryl" in the present invention means a monovalent monocyclic or bicyclic aromatic hydrocarbon group of 6 to 10 ring atoms, such as phenyl or naphthyl, especially phenyl, but is not limited thereto.
The term "optionally substituted" means that the relevant group may or may not be substituted with a substituent. Where the groups are said to be optionally substituted, there are preferably from 1 to 5 substituents, more preferably from 1 to 3 substituents, still more preferably 1 or 2 substituents. Where a group is said to be optionally substituted, and where more than one substituent is present for said optional substitution of the group, the more than one substituents may be the same or different. The substituent may be an alkyl group, a halogen group, a cyano group, a nitro group, an aryl group, a cycloalkyl group, a heterocyclic group, an amide group, an ester group, or the like, but is not limited thereto.
The invention provides a preparation method of a compound shown in a formula (I), which comprises the following steps:
Step one, reacting a compound of formula III with dichloroacetic acid or ester thereof and magnesium metal in the presence of DMF and/or DMAC to prepare a compound of formula II;
step two, preparing a compound of the formula I from the compound of the formula II in the presence of acid and sodium nitrite,
The synthetic route is as follows:
wherein,
X is selected from one of optionally substituted alkyl, optionally substituted alkoxy, cyano, ester, nitro, amide, halogen and haloalkyl; preferably optionally substituted C 1-C6 alkyl, optionally substituted C 1-C6 alkoxy, cyano, ester, nitro, amide, fluoro and fluoro C 1-C6 alkyl; particularly preferred is one of -CH3、-C2H5、-C3H7、-C4H9、-C5H11、-C6H13、-OCH3、-OC2H5、-OC3H7、-OC4H9、-OC5H11、-OC6H13、-CN、-COO(CH3)、-COO(C2H5)、-COO(C3H7)、-COO(C4H9)、-COO(C5H11)、-COO(C6H13)、-NO2、-CO(NH2)、-F、-CF3、-CHF2 and CH 2 F;
r 1 is selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted alkoxy-alkyl, optionally substituted cycloalkyl, optionally substituted heterocyclyl, and optionally substituted aryl; preferably hydrogen, optionally substituted C 1-C6 alkyl, optionally substituted C 1-C6 alkoxy-C 1-C6 alkyl, optionally substituted C 3-C8 cycloalkyl, optionally substituted heterocyclyl, Particularly preferred are -H、-CH3、-C2H5、-C3H7、-C4H9、-C5H11、-C6H13、-CH2OCH3、-CH2OC2H5、-CH2OC3H7、-CH2OC4H9、-CH2CH2OCH3、-CH2CH2OC2H5、-CH2CH2OC3H7、-CH2CH2OC4H9、-C3H6OCH3、-C3H6OC2H5、-C3H6OC3H7、-C4H8OCH3、-C4H8OC2H5、-C5H10OCH3In one of the above-mentioned steps,
R 2 is selected from hydrogen, optionally substituted alkyl; preferably one of hydrogen, methyl and ethyl;
n is selected from natural numbers from 0 to 5, particularly preferably 0, 1,2 and 3.
Preferably, in the preparation method, the first step comprises adding a compound of formula III, magnesium metal, dichloroacetic acid or an ester thereof, DMF and/or DMAC into a solvent, and reacting at-10-100 ℃ for 1-8h.
More preferably, in the first step, one of the compound of formula III, magnesium metal, dichloroacetic acid or an ester thereof, DMF and/or DMAC is added in portions or drops to the reaction system, so that the reaction can be prevented from being too fast.
Preferably, in step one, the molar ratio of magnesium, the compound of formula III and dichloroacetic acid or its esters is from 1 to 5:1:1 to 3, and DMF and/or DMAC is added in an amount of from 1 to 100 equivalents of the compound of formula III. The solvent in the first step can be one or more of DMF, DMAC, diethyl ether, tetrahydrofuran, acetonitrile, DMSO, toluene, isopropyl ether, 1, 4-dioxane and methyl tertiary butyl ether; when the solvent in the first step is DMF and/or DMAC, magnesium, the compound of formula III and dichloroacetic acid or ester thereof are respectively added into a solvent system of DMF and/or DMAC for reaction. Preferably, after the reaction in the first step is finished, pouring the mixture into acid water for quenching, and taking an organic layer or taking the organic layer after extraction by toluene to remove a solvent to obtain the compound of the formula II.
In the second step of the preparation method, a proper amount of solvent is taken, the compound of the formula II, acid and sodium nitrite are added, and the reaction is carried out for 1 to 8 hours at the temperature of 0 to 100 ℃ to obtain the compound of the formula I after the reaction is finished. Wherein the solvent is one or more of ethyl acetate, acetone, acetic acid, petroleum ether, acetonitrile, cyclohexane, tetrahydrofuran, 1, 4-dioxane, diethyl ether, isopropyl ether, methyl tertiary butyl ether and toluene, and the acid is inorganic acid or organic acid, and the inorganic acid is preferably one of hydrochloric acid, sulfuric acid, nitric acid and phosphoric acid; the organic acid is preferably one or more of formic acid, acetic acid, oxalic acid, methanesulfonic acid and trifluoroacetic acid.
The experimental methods used in the following examples are all conventional methods unless otherwise specified; the reagents, materials, etc. used in the examples described below are commercially available unless otherwise specified.
EXAMPLE 1 Synthesis of 5-phenyl-4, 5-dihydroisoxazole-3-carboxylic acid ethyl ester
50Ml of diethyl ether was taken, 2.08g of styrene, 1.2g of magnesium and 3.14g of ethyl dichloroacetate were added, 2.5gDMF g of ethyl dichloroacetate were added dropwise at 25 ℃ and reacted for 1 hour, after the reaction was completed, the mixture was poured into aqueous hydrochloric acid solution to quench, and the organic layer was taken and concentrated to remove the solvent to obtain 3.74g of ethyl 2-phenylcyclopropanecarboxylate.
50Ml of ethyl acetate was taken, 3.74g of ethyl 2-phenylcyclopropanecarboxylate, 0.39g of concentrated hydrochloric acid and 1.52g of sodium nitrite were added to react for 3 hours at 5 ℃, water was added after the reaction was completed, and the ethyl acetate layer was taken to concentrate and remove the solvent to obtain 4.24g of ethyl 5-phenyl-4, 5-dihydroisoxazole-3-carboxylate, the total yield was 96.7%, and the purity was 99.8%.
1HNMR(300MHz,CDCl3)δ7.27-7.43(m,5H),δ5.77-5.83(t,1H),δ4.34-4.41(q,2H),δ3.60-3.71(q,1H),δ3.19-3.28(q,1H),δ1.37-1.42(t,3H)
EXAMPLE 2 Synthesis of 5-methyl-5-p-toluene-4, 5-dihydroisoxazole-3-carboxylic acid
50Ml of DMF was taken, 2.64g of 1-isopropenyl-4-methylbenzene and 2.58g of dichloroacetic acid were added, 1.5g of magnesium was added in portions, the mixture was reacted at 80℃for 1 hour, after the reaction was completed, the mixture was cooled to room temperature and poured into aqueous hydrochloric acid for quenching, and after toluene extraction, an organic layer was taken and the solvent was concentrated and removed to obtain 3.73g of 2-methyl-2-p-tolylcyclopropane carboxylic acid.
50Ml of acetic acid is taken, 3.73g of 2-methyl-2-p-tolylcyclopropane carboxylic acid, 0.42g of sulfuric acid and 1.38g of sodium nitrite are added for reaction for 2 hours at 40 ℃, water is added after the reaction is finished, an organic layer is taken after toluene extraction, and the solvent is removed by concentration to obtain 4.22g of 5-methyl-5-p-toluene-4, 5-dihydro-isoxazole-3-carboxylic acid, the total yield is 96.2%, and the purity is 99.4%.
EXAMPLE 3 Synthesis of 5- (3, 5-dimethoxy-phenyl) -5-methoxymethyl-4, 5-dihydroisoxazole-3-carboxylic acid methyl ester
250Ml of acetonitrile was added, followed by addition of 16.68g of 1, 3-dimethoxy-5- (1-methoxymethyl-vinyl) -benzene, 4.0g of magnesium and 10.6 gDMAC. Mu.l of a solution of methyl dichloroacetate in acetonitrile (containing 11.44g of methyl dichloroacetate) at 50℃were added dropwise, the mixture was allowed to react for 2 hours, cooled to room temperature, poured into an aqueous sulfuric acid solution and quenched, and after extraction with toluene, the organic layer was concentrated to remove the solvent to obtain 22.08g of methyl 2- (3, 5-dimethoxy-phenyl) -2-methoxymethyl-cyclopropanecarboxylate.
80Ml of tetrahydrofuran, 5.52g of methyl 2- (3, 5-dimethoxy-phenyl) -2-methoxymethyl-cyclopropanecarboxylate, 0.38g of nitric acid and 2.07g of sodium nitrite are taken and reacted for 1.5 hours at 50 ℃, water is added after the reaction, and after toluene extraction, an organic layer is taken and concentrated to remove a solvent to obtain 5.93g of methyl 5- (3, 5-dimethoxy-phenyl) -5-methoxymethyl-4, 5-dihydro-isoxazole-3-carboxylate, wherein the total yield is 95.9 percent and the purity is 99.3 percent.
EXAMPLE 4 Synthesis of 5- (3, 5-dimethoxy-phenyl) -5-methoxymethyl-4, 5-dihydroisoxazole-3-carboxylic acid methyl ester
80Ml of tetrahydrofuran, 5.52g of methyl 2- (3, 5-dimethoxy-phenyl) -2-methoxymethyl-cyclopropanecarboxylate (sample synthesized in example 3), 0.36g of acetic acid and 2.07g of sodium nitrite were taken and reacted at 50℃for 1.5 hours, water was added after the reaction was completed, and after extraction of toluene, an organic layer was taken and concentrated to remove the solvent to obtain 5.36g of methyl 5- (3, 5-dimethoxy-phenyl) -5-methoxymethyl-4, 5-dihydroisoxazole-3-carboxylate, the total synthesis yield was 86.6% and the purity was 98.1%.
EXAMPLE 5 Synthesis of 5- (3, 5-dimethoxy-phenyl) -5-methoxymethyl-4, 5-dihydroisoxazole-3-carboxylic acid methyl ester
80Ml of tetrahydrofuran, 5.52g of methyl 2- (3, 5-dimethoxy-phenyl) -2-methoxymethyl-cyclopropanecarboxylate (sample synthesized in example 3), 0.36g of acetic acid and 2.07g of sodium nitrite are taken and reacted at 50 ℃ for 6 hours, water is added after the reaction, an organic layer is taken after toluene extraction and concentrated to remove a solvent to obtain 5.88g of methyl 5- (3, 5-dimethoxy-phenyl) -5-methoxymethyl-4, 5-dihydro-isoxazole-3-carboxylate, the total synthesis yield is 95.1 percent, and the purity is 99.1 percent.
EXAMPLE 6 Synthesis of 5-cyclohexyl-5- (3, 4, 5-trimethyl-phenyl) -4, 5-dihydroisoxazole-3-carboxylic acid isopropyl ester
100Ml of toluene was taken, 4.57g of 5- (1-cyclohexyl-vinyl) -1,2, 3-trimethylbenzene, 3.42g of isopropyl dichloroacetate and 17.4gDMAC g of magnesium were added in portions at 5℃and after 3 hours of reaction, 2.2g of magnesium was added and quenched by pouring into an aqueous sulfuric acid solution, and the organic layer was concentrated to remove the solvent to give 6.37g of isopropyl 2-cyclohexyl-2- (3, 4, 5-trimethyl-phenyl) -cyclopropanecarboxylate.
80Ml of acetonitrile was taken, 6.37g of isopropyl 2-cyclohexyl-2- (3, 4, 5-trimethyl-phenyl) -cyclopropanecarboxylate, 0.92g of formic acid, 1.38g of sodium nitrite were added for reaction at 70 ℃ for 1 hour, water was added after the reaction was completed, and after toluene extraction, the organic layer was taken and concentrated to remove the solvent to obtain 6.38g of isopropyl 5-cyclohexyl-5- (3, 4, 5-trimethyl-phenyl) -4, 5-dihydro-isoxazole-3-carboxylate, which was 89.2% in total yield and 98.3% in purity.
EXAMPLE 7 Synthesis of 5, 5-diphenyl-4, 5-dihydroisoxazole-3-carboxylic acid ethyl ester
80Ml of DMF was taken, 3.60g of stilbene and 3.14g of ethyl dichloroacetate were added, 0.98g of magnesium was added in portions at 60℃and after 2h of reaction, the mixture was cooled to room temperature and poured into aqueous hydrochloric acid for quenching, after extraction with toluene the organic layer was taken and concentrated to remove 5.22g of ethyl 2, 2-diphenyl-cyclopropanecarboxylate as solvent.
80Ml of acetone is taken, 5.22g of ethyl 2, 2-diphenyl-cyclopropanecarboxylate, 0.68g of trifluoroacetic acid and 1.8g of sodium nitrite are added for reaction for 3 hours at 25 ℃, water is added after the reaction is finished, an organic layer is taken after toluene extraction, and the solvent is removed by concentration to obtain 5.70g of ethyl 5, 5-diphenyl-4, 5-dihydro-isoxazole-3-carboxylate, the total yield is 96.5 percent, and the purity is 99.5 percent.
1HNMR(300MHz,DMSO)δ7.26-7.44(m,10H),δ4.19-4.26(q,2H),δ3.60-3.71(q,1H),δ3.90(s,2H),δ1.21-1.26(t,3H)
EXAMPLE 8 Synthesis of 5- (2-cyano-4-fluoro-5-nitro-phenyl) -5-pyridin-3-yl-4, 5-dihydroisoxazole-3-carboxylic acid methyl ester
400Ml of tetrahydrofuran are taken, 21.52g of 5-fluoro-4-nitro-2- (1-pyridin-3-yl-vinyl) -benzonitrile, 11.44g of methyl dichloroacetate and 29.2gDMF g of magnesium are added in portions at 50℃and after 2h of reaction, cooled to room temperature and quenched in aqueous hydrochloric acid, the organic layer is extracted with toluene and concentrated to remove 25.92g of methyl 2- (2-cyano-4-fluoro-5-nitro-phenyl) -2-pyridin-3-ylcyclopropane carboxylate as solvent.
100Ml of diethyl ether, 6.48g of methyl 2- (2-cyano-4-fluoro-5-nitro-phenyl) -2-pyridin-3-yl cyclopropane carboxylate, 1.17g of phosphoric acid, 1.93g of sodium nitrite and the reaction at 30 ℃ for 1 hour are taken, water is added after the reaction is finished, and an organic layer is taken and concentrated to obtain 6.68g of methyl 5- (2-cyano-4-fluoro-5-nitro-phenyl) -5-pyridin-3-yl-4, 5-dihydro isoxazole-3-carboxylate, wherein the total yield is 90.2 percent and the purity is 98.9 percent.
EXAMPLE 9 Synthesis of 5- (2-cyano-4-fluoro-5-nitro-phenyl) -5-pyridin-3-yl-4, 5-dihydroisoxazole-3-carboxylic acid methyl ester
100Ml of diethyl ether, 6.48g of methyl 2- (2-cyano-4-fluoro-5-nitro-phenyl) -2-pyridin-3-yl cyclopropane carboxylate (a synthetic sample of example 8), 1.08g of oxalic acid, 1.93g of sodium nitrite are taken and reacted for 1 hour at 30 ℃, water is added after the reaction is finished, and an organic layer is taken and concentrated to obtain 6.03g of methyl 5- (2-cyano-4-fluoro-5-nitro-phenyl) -5-pyridin-3-yl-4, 5-dihydro-isoxazole-3-carboxylate, wherein the total synthetic yield is 81.4% and the purity is 97.4%.
EXAMPLE 10 Synthesis of 5- (2-cyano-4-fluoro-5-nitro-phenyl) -5-pyridin-3-yl-4, 5-dihydroisoxazole-3-carboxylic acid methyl ester
100Ml of diethyl ether, 6.48g of methyl 2- (2-cyano-4-fluoro-5-nitro-phenyl) -2-pyridin-3-yl cyclopropane carboxylate (a synthetic sample of example 8), 1.08g of oxalic acid, 1.93g of sodium nitrite are taken and reacted for 7 hours at 30 ℃, water is added after the reaction is finished, and an organic layer is taken and concentrated to obtain 6.64g of methyl 5- (2-cyano-4-fluoro-5-nitro-phenyl) -5-pyridin-3-yl-4, 5-dihydro-isoxazole-3-carboxylate, wherein the total synthetic yield is 89.7 percent and the purity is 98.7 percent.
Finally, it should be noted that: the above embodiments are only for illustrating the technical solution of the present invention, and are not limiting; those of ordinary skill in the art will appreciate that: the technical scheme described in the foregoing embodiments can be modified or some technical features thereof can be replaced by equivalents; such modifications and substitutions do not depart from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims (9)

1. A process for the preparation of a compound of formula I comprising the steps of:
Step one, reacting a compound of formula III with dichloroacetic acid or ester thereof and magnesium metal in the presence of DMF and/or DMAC to prepare a compound of formula II;
step two, preparing a compound of the formula I from the compound of the formula II in the presence of acid and sodium nitrite,
The synthetic route is as follows:
wherein,
X is selected from one of optionally substituted alkyl, optionally substituted alkoxy, cyano, ester, nitro, amide, halogen and haloalkyl;
R 1 is selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted alkoxy-alkyl, optionally substituted cycloalkyl, optionally substituted heterocyclyl, and optionally substituted aryl;
R 2 is selected from hydrogen, optionally substituted alkyl;
n is selected from natural numbers from 0 to 5.
2. The method according to claim 1, wherein,
X is selected from one of optionally substituted C 1-C6 alkyl, optionally substituted C 1-C6 alkoxy, cyano, ester, nitro, amide, fluoro and fluoro C 1-C6 alkyl;
R 1 is selected from the group consisting of hydrogen, optionally substituted C 1-C6 alkyl, optionally substituted C 1-C6 alkoxy-C 1-C6 alkyl, optionally substituted C 3-C8 cycloalkyl, optionally substituted heterocyclyl,
R 2 is selected from one of hydrogen, methyl and ethyl.
3. The preparation method according to claim 1 or 2, wherein X is selected from one of -CH3、-C2H5、-C3H7、-C4H9、-C5H11、-C6H13、-OCH3、-OC2H5、-OC3H7、-OC4H9、-OC5H11、-OC6H13、-CN、-COO(CH3)、-COO(C2H5)、-COO(C3H7)、-COO(C4H9)、-COO(C5H11)、-COO(C6H13)、-NO2、-CO(NH2)、-F、-CF3、-CHF2 and CH 2 F;
r 1 is selected from -H、-CH3、-C2H5、-C3H7、-C4H9、-C5H11、-C6H13、-CH2OCH3、-CH2OC2H5、-CH2OC3H7、-CH2OC4H9、-CH2CH2OCH3、-CH2CH2O C2H5、-CH2CH2O C3H7、-CH2CH2OC4H9、-C3H6OCH3、-C3H6O C2H5、-C3H6O C3H7、-C4H8OCH3、-C4H8O C2H5、-C5H10O CH3One of them;
n is selected from 0, 1,2 and 3.
4. The process according to claim 1, wherein step one comprises adding a compound of formula iii, magnesium, dichloroacetic acid or an ester thereof, DMF and/or DMAC to a solvent and reacting at-10-100 ℃.
5. The process according to claim 1 or 4, wherein in the first step, one of the compound of formula III, magnesium, dichloroacetic acid or an ester thereof, DMF and/or DMAC is added in portions or added dropwise to the reaction system.
6. The process according to claim 5, wherein in the step one, the molar ratio of magnesium, the compound of formula III and dichloroacetic acid or an ester thereof is 1 to 5:1:1 to 3, and DMF and/or DMAC is added in an amount of 1 to 100 equivalents of the compound of formula III.
7. The process according to claim 6, wherein the solvent in the first step is one or more of DMF, DMAC, diethyl ether, tetrahydrofuran, acetonitrile, DMSO, toluene, isopropyl ether, 1, 4-dioxane, and methyl tert-butyl ether.
8. The process according to any one of claims 1 to 7, wherein in step two, the compound of formula i is prepared by adding the compound of formula ii, an acid and sodium nitrite in a suitable amount of solvent and reacting at 0 to 100 ℃.
9. The preparation method according to claim 8, wherein the solvent in the second step is one or more of ethyl acetate, acetone, acetic acid, petroleum ether, acetonitrile, cyclohexane, tetrahydrofuran, 1, 4-dioxane, diethyl ether, isopropyl ether, methyl tertiary butyl ether and toluene; the acid in the second step is an inorganic acid or an organic acid, the inorganic acid is preferably one or more of hydrochloric acid, sulfuric acid, nitric acid and phosphoric acid, and the organic acid is preferably one or more of formic acid, acetic acid, oxalic acid, methanesulfonic acid and trifluoroacetic acid.
CN202410054241.8A 2024-01-15 2024-01-15 Preparation method of 4, 5-dihydro-isoxazole-3-carboxylic acid compound Pending CN117903074A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202410054241.8A CN117903074A (en) 2024-01-15 2024-01-15 Preparation method of 4, 5-dihydro-isoxazole-3-carboxylic acid compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202410054241.8A CN117903074A (en) 2024-01-15 2024-01-15 Preparation method of 4, 5-dihydro-isoxazole-3-carboxylic acid compound

Publications (1)

Publication Number Publication Date
CN117903074A true CN117903074A (en) 2024-04-19

Family

ID=90686490

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202410054241.8A Pending CN117903074A (en) 2024-01-15 2024-01-15 Preparation method of 4, 5-dihydro-isoxazole-3-carboxylic acid compound

Country Status (1)

Country Link
CN (1) CN117903074A (en)

Similar Documents

Publication Publication Date Title
CN108570041B (en) Preparation method of isoxazoline-containing uracil compound
CN106164052A (en) For the method preparing grace miscellaneous Shandong amine
CN114315823B (en) Intermediate of berberine hydrochloride and analogues thereof and preparation method thereof
AU640006B2 (en) An improved process for the preparation of substituted indolone derivatives
CN112390725B (en) Preparation method of amide compound
US9840459B2 (en) Process for preparing cis-alkoxy-substituted spirocyclic phenylacetylamino acid esters and cis-alkoxy-substituted spirocyclic 1H-pyrrolidine-2,4-dione derivatives
JPS63310865A (en) Manufacture of 3-cyano-4-aryl-pyrroles
CN117903074A (en) Preparation method of 4, 5-dihydro-isoxazole-3-carboxylic acid compound
KR100720220B1 (en) Process for producing substituted aniline compound
CA2127945C (en) Process of producing 2-cyano-4-oxo-4h-benzopyran compounds
JP5467725B2 (en) Method for producing cyclic lactam compound and Beckmann rearrangement catalyst
AU2021302173B2 (en) Preparation method for phenylisoxazoline compound
TWI788289B (en) Method for preparing cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives
CA2871694A1 (en) Manufacture of 1-substituted methylidene compounds
US20040199002A1 (en) Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor
US20210024531A1 (en) Process for producing herbicidal pyridazinone compounds
KR20080110729A (en) Process for the preparation of 2-(4-hydroxy-3-morfolynil)-2-cyclohexenone
JPH0662577B2 (en) Process for producing 1-methyl-5-hydroxypyrazole
Kirschke et al. Surprising reactions or special azoolefins-self-arylation, indole ring closure, mild chlorine substitution, and “tert. amino effect”
JP2009242243A (en) alpha-HYDROXYIMINO CARBOXYLIC ACID ESTER DERIVATIVE AND METHOD FOR PRODUCING alpha-AMINO-alpha-HALOALKYL CARBOXYLIC ACID ESTER DERIVATIVE BY USING THE SAME
JPH0735361B2 (en) Hydrazone derivative and method for producing the same
US10604495B2 (en) Process for preparing substituted phenylisoxazoline derivatives
JP3005080B2 (en) Method for producing cyclopenta [d] pyrimidin-4-ones
IL108118A (en) Preparation of hydroxylamine ethers and their salts and novel oximino derivatives used therefor
WO1997014688A1 (en) A PROCESS FOR THE PREPARATION OF α-CHLOROMETHYLPHENYLACETIC ACID DERIVATIVES

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination